Peptidoglycan transpeptidase and DD-carboxypeptidase have been detected in isolated membranes of Pseudomonas aeruginosa. Cephalosporins and penicillins fail to inhibit the transpeptidase at concentrations as high as 100 ,sg/ml. DD-Carboxypeptidase, on the other hand, is sensitive to inhibition by ,B-lactam antibiotics. The presence of dimethyl sulfoxide in the reaction mixture results in a twofold stimulation of peptidoglycan formation, whereas DD-carboxypeptidase is inhibited approximately 30%. Maximum stimulation of transpeptidase occurs in the presence of both dimethyl sulfoxide and a f3-lactam antibiotic. This is in sharp contrast to the transpeptidase from Escherichia coli, which is sensitive to inhibition by penicillins and cephalosporins.
The final biosynthetic reaction in bacterial cell wall synthesis is the elimination of a D-alanine residue accompanied by the formation of an interpeptide bridge (see reference 13 for review and other references). This terminal reaction is catalyzed by the enzyme peptidoglycan transpeptidase. Based on a structural similarity between the substrate for the transpeptidase and penicillins, Tipper and Strominger (14) proposed that this enzyme was the site of penicillin action. Moreover, they suggested that penicillins would bind irreversibly to the transpeptidase. Subsequently, this enzyme was discovered in a particulate fraction from cell-free Escherichia coli extracts and found to be sensitive to penicillins (1, 4, 5) . The inhibition of transpeptidation appeared to be irreversible (5).
DD-Carboxypeptidase has also been found in these membrane fractions (6) . This enzyme, which is capable of hydrolyzing the terminal D-alanine residue, is also sensitive to penicillin. It has been suggested that such activity may be the result of an uncoupled transpeptidase (7, 9) or a separate entity (2) .
In addition to E. coli, transpeptidase activity and DD-carboxypeptidase activity has been found in a number of gram-positive microorganisms (2, 8, 9, 13) . To date, however, E. coli represents the only gram-negative bacteria from which the transpeptidase has been studied. This report concerns the successful isolation of both transpeptidase and DD-carboxypeptidase from another gram-negative organism, Pseudomonas aeruginosa. Evidence is presented which shows that the activity of,-lactam antibiotics on the transpeptidase from this organism is substantially different from that which has been reported for the enzymes from either E. coli or gram-positive organisms.
MATERIALS AND METHODS
Bacterial strain. P. aeruginosa-173 is a clinical isolate which has been maintained on brain-heart infusion agar, subcultured biweekly, and stored at 4 C.
Growth and harvest of cells. A seed culture that contained 400 ml of medium containing 0.8% nutrient broth, 0.8% yeast extract, 0.4% K2HOP4, and 0.4% glucose (autoclaved and added separately) was prepared by the addition of 5 ml of an 18-h culture and grown to mid log phase at 37 C. This culture was added to 7.6 liters of fresh, prewarmed medium in a New Brunswick fermentor. When growth reached mid to late log phase, the culture was chilled, and the cells were harvested by continuous flow centrifugation in a Sorvall RC-2 centrifuge.
Preparation of enzymes. The enzymes were prepared by a modification of the procedure of Matsuhashi et al. (11) . Cells (25 g, wet weight) were suspended to a final volume of 80 ml in 0.05 M tris(hydroxymethyl)aminomethane, pH 7.5, buffer, containing 10-4 M MgCl2 and 10-3 M mercaptoethanol (Buffer A), and disrupted in a French pressure cell. The debris was removed by centrifugation. The supernatant solution was centrifuged at 100,000 x g, arid the resulting pellet was washed twice with Buffer A and finally suspended in 0.7 ml of the same buffer. Membranes prepared in this manner served as the source of the enzymes and could be stored for periods exceeding 6 months at -40 C with no appreciable loss in activity. The protein concentration was 52 mg/ml, as determined by the method of Lowry et al. (10) .
Preparation of substrate. The substrate, uridine- Table 2 . It is apparent that there is less D-alanine released as the level of Me2SO is increased from 4 to 16%, indicating a suppression of DD-carboxypeptidase activity. However, the degree of DD-carboxypeptidase inhibition at 8% Me2SO does not appear sufficient to explain the two-to threefold increase in peptidoglycan synthesis usually observed at this concentration.
Since our membrane preparations contained larger amounts of carboxypeptidase, several compounds were examined for their ability to inhibit this enzyme. Such inhibition could conserve substrate (non-cross-linked peptidoglycan) for the synthesis of insoluble (cross-linked) peptidoglycan. Moreover, if such a compound had no effect on transpeptidase activity, much larger amounts of insoluble peptidoglycan should be observed. The results of these experiments show that all the antibiotics tested inhib- 7, 1975 on September 23, 2017 by guest http://aac.asm.org/ Downloaded from ited carboxypeptidase activity (Table 3) . At a concentration of 10 tig/ml, cephalexin appeared to be the best inhibitor of this enzyme; however, at 100 ,ug/ml ampicillin and carbenicillin were the most effective inhibitors.
When transpeptidase activity was measured under similar coinditions, it became evident that all of the antibiotics which inhibited the DD-carboxypeptidaso not only failed to inhibit the transpeptidase, but also increased the formation of insoluble peptidoglycap, the product of the transpeptidase reaction (Table 4 ). This increase in transpeptidase activity was not observed in the absence of Me2SO. The liberated D-alanine in these experiments is the result of residual DD-carboxypeptidase activity (Table  3 ) and transpeptidase activity. DISCUSSION These experiments have demonstrated the presence of peptidoglycan transpeptidase in membranes of P. aeruginosa. The transpeptidase from this organism appears not to be similar to the transpeptidase of E. coli; the E. coli enzyme is inhibited by penicillins and cephalosporins (13) , whereas the P. aeruginosa enzyme is not. The membrane isolates from Pseudomonas also contain large amounts of DD-carboxypeptidase activity. We believe that initially we were unable to detect transpeptidase activity because the carboxypeptidase rapidly degraded the uridine-diphosphate-N-acetyl-muramyl-pentapeptide precursor. But, since the carboxypeptidase is highly susceptible to inhibition by both penicillins and cephalosporins, we were able to detect transpeptidase activity in the presence of these antibiotics. Cephalexin ( When the carboxypeptidase was inhibited by these antibiotics in the presence of Me2SO, we observed an increase in the formation of insoluble peptidoglycan. Clearly, Pseudomonas transpeptidase activity is not inhibited by 63-lactam antibiotics. A possible explanation for the lack of transpeptidase inhibition could be provided by assuming that all of the antibiotic is bound by the carboxypeptidase. However, maximum binding of cephalexin to carboxypeptidase was observed at 10 ,ug of cephalexin per ml (Table  3) . When transpeptidase activity was assayed in the presence of both cephalexin (10 gg/ml and another antibiotic (either 10 or 100 ug/ml), the maximum inhibition observed was only 20% (Table 4 ; unpublished data).
The addition of Me2SO to the reaction mixture provided a method by which it was possible to separate the transpepti'dase and carboxypeptidase reactions while slightly suppressing DDcarboxypeptidase activity. Although the exact function of Me2SO remains unknown, it may be postulated that it makes the particular enzyme more available to the substrate.
Transpeptidase has been described as the site of cephalosporin and penicillin intrinsic activity by Strominger and others (13) . Our studies indicate that this is not the case for P. aeruginosa; none of the antibiotics herein tested had a significant effect on the transpeptidase from Pseudomonas. Even carbenicillin, a penicillin known to have cidal effects on Pseudomonas, was essentially inactive as an inhibitor of transpeptidase. Thus, the precise mechanism of action of penicillins against Pseudomonas remains unknown.
